Eva Feldman MD Tutorial Profile
gt;gt; Eva Feldman: So when I completedcollege I had the dilemma whether I wanted to go straight into medical school or whetherI also wanted to do research because when I was in college, I got very excited about thebrain and had, again a professor who told me that he felt that in the next centuryall the major advances in medicine and in research we're going to be in thenervous system particularly in the brain. So when I finished college, I decidedoh maybe I'll get a PhD and a M.D. And so I started my graduatestudies first and I began in a neuroscience program atthe University of Michigan.
Fell in love with the brain completely and whenI started medical school there was no doubt from the very first day inmedical school, I said I was going to be a neurologist and I loved every day of it. One of my passions as a neurologistis also to be a neuroscientist. So I'm very privileged to have a fairlylarge laboratory that I work in with about 30 young people who do research with me. And we've become very interested overthe last 5 years in using stem cells in regenerative medicine particularly inneurodegenerative diseases in neurology.
Lou Gehrig's disease is onepassion that we have. We're also interested in Alzheimer's disease,Parkinson's disease, and Huntington's disease. So from our basic findings in the laboratory ofhow stem cells can promote nerve regeneration and protect nerve cells from dying, we'veactually begun a al trial using stem cells in patients with Lou Gehrig's disease. So it's very exciting because what I do in mybasic science laboratory I can then transition over to my al practice and ALS or LouGehrig's disease is one of the disorders that I am familiar with and I take care ofhundreds of patients with that disorder.
And so I'm able to serve as a bridgefrom the basic science to the . I can go to the and tell my patients whatI've learned in my basic science laboratory. I can go back and tell my basicscientists what my patients have taught us and they teach us so much. And so stem cells is one of the majoravenues I see translating in the near future from my laboratory to a realal and therapeutic, I hope, option for patients with Lou Gehrig's disease.
Katherine Gallagher MD
gt;gt; I think the most important part,especially when dealing with the patients, all vascular patients but in particular patientswith peripheral artery disease is kind of trying to get a comprehensive historyof when the problem began. I lot of times patients who come in andparticularly those who see me have had lots of things done sort of at others or by other physicians. So I think it's really important to kind ofgo over sort of the timeline of everything that has happened and try and getreally good records and information from the patient about the problem itself.
And then based on that information, we will thenkind of go over different treatment options, both the pros and the cons because everything,you know, has a risk benefittype thing, so we'll go over that with the patients sothat they can make a very clear decision about what they want and whatthey're willing to undergo. I always think it's important to look verycarefully at the place that you're going and at the training and the credentialsof the people that you're seeing because not everyone's eventhough everyone may do certain things or say that they do certain procedures, Ithink it's really important to find people
who really specialize in that area and see a lotof that particular problem and have experience and training that kind of backs that up. In particular for vascular surgery, we'retrained in both the interventional aspects, as well as the medical aspects,as well as the surgical aspects. So I feel it gives us a good breath inthe areas that we treat because we're able to offer minimally invasivetreatment if that's appropriate. Now that's not always appropriate. Sometimes patients are more appropriate and thedata would suggest that they would do better
with open procedures or moreof that type of option. So the fact that we can kind of offer bothoptions and just pick out what is best for the patient and also give the patientsome ability to make some decisions themselves if both options are viable, kind ofchoose which one they'd rather have. I think that's really important.